Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer
Condition(s):Prostate CancerLast Updated:June 24, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:June 24, 2013Completed
Condition(s):Prostate CancerLast Updated:June 23, 2016Completed
Condition(s):Prostate CancerLast Updated:February 11, 2013Completed
Condition(s):Stage III Prostate CancerLast Updated:July 3, 2018Withdrawn
Condition(s):Stage III Prostate Cancer; Stage IV Prostate CancerLast Updated:March 7, 2023Completed
Condition(s):Stage III Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8Last Updated:February 7, 2024Recruiting
Condition(s):Prostate CancerLast Updated:December 4, 2013Completed
Condition(s):Adenocarcinoma of the Prostate; Stage III Prostate CancerLast Updated:January 19, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:June 25, 2013Completed
Condition(s):Prostate CancerLast Updated:June 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.